Log in to save to my catalogue

The Role of Therapeutic Drug Monitoring of Anti–Tumor Necrosis Factor Alpha Agents in Children and A...

The Role of Therapeutic Drug Monitoring of Anti–Tumor Necrosis Factor Alpha Agents in Children and A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1768578258

The Role of Therapeutic Drug Monitoring of Anti–Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease

About this item

Full title

The Role of Therapeutic Drug Monitoring of Anti–Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease

Publisher

Oxford, UK: Oxford University Press

Journal title

Inflammatory bowel diseases, 2015-09, Vol.21 (9), p.2214-2221

Language

English

Formats

Publication information

Publisher

Oxford, UK: Oxford University Press

More information

Scope and Contents

Contents

Anti–tumor necrosis factor alpha (TNFα) therapy is effective in pediatric patients with inflammatory bowel disease (IBD) but associated with a risk of developing anti-drug antibodies (ADA) which lower the efficacy. Incorporating measurement of trough levels and ADA (therapeutic drug monitoring) may prevent the development of neutralizing ADA or cou...

Alternative Titles

Full title

The Role of Therapeutic Drug Monitoring of Anti–Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1768578258

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1768578258

Other Identifiers

ISSN

1078-0998

E-ISSN

1536-4844

DOI

10.1097/MIB.0000000000000420

How to access this item